125 related articles for article (PubMed ID: 38493544)
1. MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
Huang J; Fehr A; Jäwert F; Nilsson JA; Morris LGT; Stenman G; Andersson MK
Oral Oncol; 2024 Apr; 151():106763. PubMed ID: 38493544
[TBL] [Abstract][Full Text] [Related]
2. The value of MYB as a prognostic marker for adenoid cystic carcinoma: Meta-analysis.
Liu X; Chen D; Lao X; Liang Y
Head Neck; 2019 May; 41(5):1517-1524. PubMed ID: 30759319
[TBL] [Abstract][Full Text] [Related]
3. Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.
Ono J; Okada Y
Odontology; 2018 Jul; 106(3):238-244. PubMed ID: 29243184
[TBL] [Abstract][Full Text] [Related]
4. The incidence of MYB gene breaks in adenoid cystic carcinoma of the salivary glands and its prognostic significance.
Broz M; Steiner P; Salzman R; Hauer L; Starek I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):417-22. PubMed ID: 27174194
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of MYB promoter methylation in salivary adenoid cystic carcinoma.
Shao C; Bai W; Junn JC; Uemura M; Hennessey PT; Zaboli D; Sidransky D; Califano JA; Ha PK
Oral Oncol; 2011 Apr; 47(4):251-5. PubMed ID: 21324728
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
[TBL] [Abstract][Full Text] [Related]
7. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.
Ho AS; Ochoa A; Jayakumaran G; Zehir A; Valero Mayor C; Tepe J; Makarov V; Dalin MG; He J; Bailey M; Montesion M; Ross JS; Miller VA; Chan L; Ganly I; Dogan S; Katabi N; Tsipouras P; Ha P; Agrawal N; Solit DB; Futreal PA; El Naggar AK; Reis-Filho JS; Weigelt B; Ho AL; Schultz N; Chan TA; Morris LG
J Clin Invest; 2019 Oct; 129(10):4276-4289. PubMed ID: 31483290
[TBL] [Abstract][Full Text] [Related]
8. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma.
Tadi S; Cheung VK; Lee CS; Nguyen K; Luk PP; Low TH; Palme C; Clark J; Gupta R
Pathology; 2023 Jun; 55(4):456-465. PubMed ID: 37055331
[TBL] [Abstract][Full Text] [Related]
9. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.
Mitani Y; Li J; Rao PH; Zhao YJ; Bell D; Lippman SM; Weber RS; Caulin C; El-Naggar AK
Clin Cancer Res; 2010 Oct; 16(19):4722-31. PubMed ID: 20702610
[TBL] [Abstract][Full Text] [Related]
11. MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.
Rettig EM; Tan M; Ling S; Yonescu R; Bishop JA; Fakhry C; Ha PK
Laryngoscope; 2015 Sep; 125(9):E292-9. PubMed ID: 25963073
[TBL] [Abstract][Full Text] [Related]
12. Differences in MYB expression and gene abnormalities further confirm that salivary cribriform basal cell tumors and adenoid cystic carcinoma are two distinct tumor entities.
Tian Z; Li L; Zhang CY; Gu T; Li J
J Oral Pathol Med; 2016 Oct; 45(9):698-703. PubMed ID: 26711587
[TBL] [Abstract][Full Text] [Related]
13. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
Brill LB; Kanner WA; Fehr A; Andrén Y; Moskaluk CA; Löning T; Stenman G; Frierson HF
Mod Pathol; 2011 Sep; 24(9):1169-76. PubMed ID: 21572406
[TBL] [Abstract][Full Text] [Related]
14. MYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens.
Pusztaszeri MP; Sadow PM; Ushiku A; Bordignon P; McKee TA; Faquin WC
Cancer Cytopathol; 2014 Apr; 122(4):257-65. PubMed ID: 24302647
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
Brayer KJ; Frerich CA; Kang H; Ness SA
Cancer Discov; 2016 Feb; 6(2):176-87. PubMed ID: 26631070
[TBL] [Abstract][Full Text] [Related]
16. MYB-NFIB gene fusions identified in archival adenoid cystic carcinoma tissue employing NanoString analysis: an exploratory study.
McIntyre JB; Ko JJ; Siever J; Chan AMY; Simpson RHW; Hao D; Lau HY
Diagn Pathol; 2019 Jul; 14(1):78. PubMed ID: 31301736
[TBL] [Abstract][Full Text] [Related]
17. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
Bell D; Bell AH; Bondaruk J; Hanna EY; Weber RS
Cancer; 2016 May; 122(10):1513-22. PubMed ID: 26953815
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome.
Mitani Y; Roberts DB; Fatani H; Weber RS; Kies MS; Lippman SM; El-Naggar AK
PLoS One; 2013; 8(6):e66778. PubMed ID: 23825564
[TBL] [Abstract][Full Text] [Related]
19. MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma.
Panaccione A; Zhang Y; Ryan M; Moskaluk CA; Anderson KS; Yarbrough WG; Ivanov SV
Stem Cell Res; 2017 May; 21():160-166. PubMed ID: 28500913
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of MYB/NFIB gene fusion with the grade and prognosis of head and neck adenoid cystic carcinoma and the concordance of two detection methods].
Zhu YL; Li Y; Mu JL; Liu WC; Li X; Lu HZ
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):149-154. PubMed ID: 38281782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
